Connect with us

Hi, what are you looking for?

Jewish Business News

Leadership & A-List

Tel Aviv Stock Exchange (TASE) Board Appoints Amnon Neubach Chairman

Neubach has served on several company boards and in prominent public sector posts.

Amnon-Neubach -  Tel Aviv Stock Exchange (TASE) -GLOBES

The board of directors of the Tel Aviv Stock Exchange has a new chairman, after eight months without one. Today, the board confirmed the recommendation of the search committee, and appointed Amnon Neubach to the chairmanship. The stock had expected about 200 candidates for the post, but in fact only 40 applied.

Thanking the committee and the board, Neubach said today, “I am convinced that together we will address the challenges facing Israel’s capital market at this time and will usher TASE into a new era.”

Adv. Bracha Litvak, who chaired the search committee, said, “Mr. Neubach brings to the post rich and varied experience in business management, in both the public and private sectors, as a director and board chairman. He possesses a broad macroeconomic outlook, and experience in leading significant change in complex organizations.”

Israel Securites Authority chairman Shmuel Hauser said, “Amnon’s rich experience in the public and private sectors and as a former chairman of major companies will assist him in leading the stock exchange, together with CEO Yossi Beinart and the directors, to new peaks, and in bringing it to its rightful position in the international and local arenas as a generator of growth in the economy and as one of the central pillars of Israeli industry.”

Published by Globes [online], Israel business news – 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...